Highlights

  • Elixinol completed the sale of its US Business in September as it shifted its focus to Australian brands.
  • Elixinol agreed to acquire Vitable through an all-scrip transaction that will increase the number of shares on issue.
  • The September quarter report showed higher gross margins alongside a small cash balance and largely drawn Debt facilities.
  • Vitable generated more than AUD 5 million in Revenue over the previous 12 months, according to Elixinol.

Elixinol Wellness (ASX:EXL) has spent the second half of 2026 reshaping its business around Australian food and wellness brands. It completed the sale of its United States business in early September and, weeks later, agreed to acquire Vitable in an all-scrip deal. Its September quarter report showed higher gross margins but a small cash balance and largely drawn debt facilities.

What Elixinol does

Elixinol develops, markets and sells hemp and other plant-derived foods, skincare and nutraceutical products. Its portfolio includes hemp food lines, the Mt. Elephant baking Brand and The Healthy Chef.

Exiting the US

According to the announcement, headline consideration was about AUD 465,000, made up of AUD 250,000 upfront and up to AUD 215,000 in deferred and contingent payments. The sale price is modest, and the main effect is to remove a part of the group the company no longer wanted to fund.

The Vitable acquisition

On 24 September 2026 Elixinol announced a binding agreement to acquire the Vitable business in an all-scrip deal valued at AUD 2.5 million plus a performance-based payment. That target is company guidance, not a result. Because the deal is paid in shares, it will increase the number of shares on issue.

On 28 October The Healthy Chef announced a push into creatine and women's wellness products, while on 7 October Mt. Elephant launched a national cake pods range.

Trading and cash

In a 13 October update, Elixinol said combined branded and bulk hemp sales were about AUD 6.41 million for the nine months to 30 September 2026, up 12%, with Gross Profit up 41%. It said it now fully supplies two major grocery programmes, both continuing into 2027, and that its Hemp Gold Protein product would return to Costco in the December quarter.

The September quarter 4C, released on 14 October, reported sales of about AUD 3.6 million, up 6%, and gross profit of about AUD 1.5 million, with gross Margin rising to 42% from 35%. Operating expenses fell 26%.

Cash was about AUD 927,000 at 30 September. Of financing facilities totalling about AUD 4.04 million, about AUD 3.96 million was drawn, leaving estimated available funding of about AUD 1.0 million, or roughly 3.1 quarters at the reported outflow rate.

Risks

The main risks are funding and execution. With facilities nearly fully drawn, the company has limited headroom if trading weakens. Integrating Vitable, reaching the revenue target and keeping major grocery and Costco programmes are not guaranteed, and the scrip consideration adds dilution. The consumer wellness market is also highly competitive.

Director trading has been mixed. Further Appendix 3Y notices for Ms Butler were lodged in September and October.

Share Trading on 16 November

The Market Capitalisation was about AUD 2.72 million.